BioCentury
ARTICLE | Company News

Genisphere, AstraZeneca deal

June 13, 2016 7:00 AM UTC

Genisphere and AstraZeneca’s MedImmune LLC unit partnered to develop nanoparticles to treat cancer. Genisphere will use its 3DNA dendrimer scaffold delivery platform, which improves drug targeting, w...